Welcome To
Alzheimer International Society™

Alzheimer International Society™ is a non-profit organization with the goal to facilitate and accelerate the research to find prevention and treatment therapeutics for Alzheimer’s disease, and to provide services and support to our stakeholders around the world.

Today there are more than 6 million people in the US and 50 million people around the world have suffered from Alzheimer’s disease.

Learn more

International United Front

Against Alzheimer’s

United Front against Alzheimer's

Alzheimer International Society has launched the International United Front Against Alzheimer™ (IUFAA) with the following objectives to:

  • Collaborate on the development of prevention and drug treatment therapy for Alzheimer.
  • Accelerate on the development of biomarkers and diagnostics.
  • Harmonize and speed up the AD drug approval processes between regional and international clinical trial systems.
  • Partner with the International Funds Against Alzheimer to raise $1 Billion to fund new concepts and clinical trials of new Alzheimer drugs with proof of safety and efficacy.
  • Focus resources to bring newly approved drugs to the market by 2025.
  • Support the evidenced-based Dementia care practices.

The International Fund Against Alzheimer’s is funded by a globally diverse group of institutional investors, including foundations, endowments, family offices, financial institutions and pension funds.

Learn more

Alzheimer Society
International Congress™

May 21-23, 2024 at the Crowne Plaza San Francisco Airport

The ASIC 2024 will highlight the latest accomplishment in
Alzheimer research and patient care. ASIC 2024 encourages new concepts and hypotheses on the etiology and potential prevention or treatment therapy. New ideas and alternatives to Amyloid cascade hypothesis such as Neurogenesis hypothesis, Tau hypothesis, Calcium hypothesis, Inflammation hypothesis, Cholinergic and Oxidative stress hypothesis, Glucose hypometabolism, Endocrine pathway, Bacteria-derived metabolites and other new ideas with supporting clinical data are welcome at the ASIC.

Learn more

Alzheimer's Drug Development Symposium (ADDS) 2024

The Alzheimer's Drug Development Symposium (ADDS) 2024 will be held in conjunction with the Alzheimer Society International Congress, May 21-23, 2024 in San Francisco.

  • The ADDS Symposium brings together leading drug developers and business leaders in the Alzheimer’s community to discuss and exchanges ideas on how to solve the translational challenges, the holy grail of medical research to find a treatment or prevention for Alzheimer’s disease.
  • The Symposium will serve as a great network opportunity for biopharmaceutical executives to explore research collaboration, technology licensing and merger & acquisition.
  • In addition, the ADDS Symposium presents a panel featuring prominent investment bankers to discuss the state of the industry, challenges and opportunities of direct investment in biopharmaceutical companies that develop therapeutic treatment and prevention of Alzheimer's disease..
Learn more
Card image cap
Membership

Alzheimer International Society™ is a professional international society for individuals interested in Alzheimer's and dementia science. Be a part of an international network of researchers, scientists, and healthcare providers with common interests in various Professional Focused Areas (PFAs)

Learn more
Card image cap
Services

In the early onset of the Alzheimer’s disease, most patients may can live relatively a normal life. However, the loved ones recognize that the patient has increasing incidence of memory lapses and fails to recognize familiar faces and things around them. In addition, the patient tends to lose the sense

Learn more
Card image cap
Research & Clinical Trials

The Alzheimer International Society™ is dedicated to foster the global effort to end Alzheimer's disease. The Society serves as the coordinating hub to interconnect with scientific, academic, government and industry thought-leaders and key stakeholders worldwide

Learn more
Card image cap
ASIC 2024- Workshops

There will be 3 workshops on May 21, 2024 on important pre-clinical and clinical aspects of drug therapeutics for the prevention and treatment of Alzheimer's disease. (details will be announced shortly)

Workshop Registration
Card image cap
Call for Abstracts

ASIC 2024 will welcome new concepts and hypotheses on the etiology and potential prevention or treatment therapy, latest clinical data and best practices in Alzheimer’s and Dementia care.

Learn more
Card image cap
Abstract Submission

The deadline for abstract submission is November 15, 2023 by 11:59 PM Pacific Standard Time.

The deadline for late breaking news of clinical trial reports to the Congress is December 15, 2023 by 11:59 PM Pacific Standard Time.

Learn more

Conference
Schedule

The Alzheimer Society International Congress™ will be held on May 21-23, 2024 at the Crowne Plaza San Francisco Airport .

The preliminary conference schedule has been posted online:

Learn more

REGISTRATION

Early-bird registration will end on January 15, 2024

Regular registration will be from January 16 to May 18, 2024

On-site registration rates will be applied from May 19 to May 23, 2024

Learn more